VGX-200

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVGX-200
Drug Alias NameVEGF-D mAb (Vegenics)VGX-200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor D inhibitors
TargetsVascular endothelial growth factor D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVegenics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVegenics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A